Key result
Elevated resting heart rate (≥70 bpm) is a strong independent predictor of clinical outcomes, and heart rate reduction with ivabradine improves coronary outcomes in stable coronary artery disease.
Why the study?
Does heart rate reduction with ivabradine improve cardiovascular outcomes in patients with stable coronary artery disease?
Does heart rate reduction with ivabradine improve cardiovascular outcomes in patients with stable coronary artery disease?
Elevated resting heart rate is a significant cardiovascular risk factor, and its targeted reduction with agents like ivabradine improves outcomes in patients with stable coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Heart rate ≥70 bpm may warrant monitoring in stable CAD; leaves open prospective confirmation of ivabradine benefit.
Jean‐Claude Tardif (2009) conducted a review in Coronary artery disease. Ivabradine / Heart rate reduction was evaluated. Elevated resting heart rate (≥70 bpm) is a strong independent predictor of clinical outcomes, and heart rate reduction with ivabradine improves coronary outcomes in stable coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: